Literature DB >> 15897536

Hormone therapy for the prevention of chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Services Task Force.

.   

Abstract

This statement summarizes the U.S. Preventive Services Task Force recommendations on hormone therapy for the prevention of chronic conditions in postmenopausal women and the supporting scientific evidence, and updates the Task Force's 2002 recommendations on hormone replacement therapy. The updated statement is based on the results of the Women's Health Initiative randomized, controlled trial, as well as the information in the 2002 summary of the evidence on this topic, which is available on the USPSTF Web site (http://www.preventiveservices.ahrq.gov).

Entities:  

Mesh:

Year:  2005        PMID: 15897536

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  31 in total

1.  Climacteric Complaints after Breast Cancer - Is HRT an Option?

Authors:  Christian F Singer
Journal:  Breast Care (Basel)       Date:  2008-06-20       Impact factor: 2.860

Review 2.  Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease.

Authors:  Durr-e-Nayab Masood; Emir C Roach; Katie G Beauregard; Raouf A Khalil
Journal:  Curr Drug Metab       Date:  2010-10       Impact factor: 3.731

Review 3.  Current breast cancer risks of hormone replacement therapy in postmenopausal women.

Authors:  Nirav R Shah; Tanping Wong
Journal:  Expert Opin Pharmacother       Date:  2006-12       Impact factor: 3.889

Review 4.  Anterior pituitary hormone replacement therapy--a clinical review.

Authors:  Christoph J Auernhammer; George Vlotides
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

5.  Criteria for the evaluation of large cohort studies: an application to the nurses' health study.

Authors:  Graham A Colditz; Deborah M Winn
Journal:  J Natl Cancer Inst       Date:  2008-06-24       Impact factor: 13.506

6.  Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society.

Authors:  Wulf H Utian; David F Archer; Gloria A Bachmann; Christopher Gallagher; Francine n Grodstein; Julia R Heiman; Victor W Henderson; Howard N Hodis; Richard H Karas; Rogerio A Lobo; JoAnn E Manson; Robert L Reid; Peter J Schmidt; Cynthia A Stuenkel
Journal:  Menopause       Date:  2008 Jul-Aug       Impact factor: 2.953

Review 7.  Postmenopausal hormone therapy and breast cancer risk: current status and unanswered questions.

Authors:  Wendy Y Chen
Journal:  Endocrinol Metab Clin North Am       Date:  2011-07-12       Impact factor: 4.741

8.  The current state of postmenopausal hormone therapy: update for neurologists and epileptologists.

Authors:  Cynthia L Harden
Journal:  Epilepsy Curr       Date:  2007 Sep-Oct       Impact factor: 7.500

9.  Treating chronic insomnia in postmenopausal women: a randomized clinical trial comparing cognitive-behavioral therapy for insomnia, sleep restriction therapy, and sleep hygiene education.

Authors:  Christopher L Drake; David A Kalmbach; J Todd Arnedt; Philip Cheng; Christine V Tonnu; Andrea Cuamatzi-Castelan; Cynthia Fellman-Couture
Journal:  Sleep       Date:  2019-02-01       Impact factor: 5.849

10.  Bone fractures and incident epithelial ovarian cancer in a prospective cohort study.

Authors:  Kim N Danforth; Catherine Schairer; Arthur Schatzkin; James V Lacey
Journal:  J Womens Health (Larchmt)       Date:  2009-11       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.